Try our Advanced Search for more refined results
Competition
-
February 09, 2026
5th Circ. Tosses Challenge To La. 340B Discount Drug Rule
A Fifth Circuit panel upheld on Monday a Louisiana law that allows the state to stop prescription drug manufacturers from blocking safety-net healthcare providers from contracting with outside pharmacies to dispense discounted medicines under the federal 340B Discount Drug program.
-
February 09, 2026
DOJ Scraps Criminal Antitrust Fragrances Probe
The U.S. Department of Justice told a New Jersey federal judge Monday that it had closed its criminal probe looking for an anticompetitive conspiracy among fragrance giants, meaning its continued presence in private price-fixing litigation against the companies was no longer necessary.
-
February 09, 2026
Italian Biathlete Lodges Appeal Of Olympic Doping Ban
Italian biathlete Rebecca Passler, who was booted from the Olympic team last week after a positive doping test, has appealed the decision to the Court of Arbitration for Sport, asserting that the test result arose from a contamination issue.
-
February 09, 2026
Fed. Circ. Sends Blood Pump Patent Fight Back To Mass.
The Federal Circuit on Monday reversed a lower court's ruling that Abiomed Inc. hasn't infringed five patents on blood pump systems and methods, while backing the part of the decision that cleared the medical device technology company of allegations it infringed a different patent.
-
February 09, 2026
Sports Flooring Makers Want Antitrust Merger Suit Tossed
A manufacturer of flooring for sporting events has asked a Utah federal judge to toss an antitrust suit from several of its distributors, casting doubt on claims that its recent acquisition of a competing company is an anticompetitive power play.
-
February 09, 2026
Commerce Probing Claims Of Mattress Duties Evasion
The U.S. Department of Commerce is opening three investigations into claims that Mexican, Malaysian and Polish exporters are dodging antidumping duties on mattresses following complaints by domestic companies such as Serta Simmons Bedding and Tempur Sealy International, the agency said Monday.
-
February 09, 2026
Competition Group Of The Year: White & Case
White & Case LLP scored early wins against algorithmic price-fixing litigation on behalf of hotel chain Four Seasons and netted a nearly $407 million judgment for client Regeneron against Amgen, earning the firm a spot as one of the 2025 Law360 Competition Groups of the Year.
-
February 09, 2026
Insurers Sued Over Nix Of $4M Coverage In Competition Fight
A Florida luxury vehicle company locked in a lawsuit with a competitor alleging deceptive trade practices was wrongfully denied insurance coverage under a directors and officers policy, forcing the auto company to fork out more than $4 million in defense costs, it told a Florida federal court.
-
February 09, 2026
Fried Frank Hires Pillsbury M&A, PE Head
Fried Frank Harris Shriver & Jacobson LLP announced Monday that it has hired the former head of Pillsbury Winthrop Shaw Pittman LLP's mergers and acquisitions and private equity practices, touting his transactional experience across a wide range of industries.
-
February 09, 2026
EU Moves To Block Meta's WhatsApp Restriction On AI Rivals
The European Union's competition regulator revealed Monday it plans to impose restrictive measures on Meta over suspicions that the tech giant has breached antitrust rules by excluding third-party artificial intelligence apps from WhatsApp.
-
February 09, 2026
2 Arnold & Porter M&A Attys Join WilmerHale In Silicon Valley
WilmerHale continues boosting its dealmaking team with attorneys from Arnold & Porter Kaye Scholer LLP, announcing Monday that two technology mergers and acquisitions experts are joining its Silicon Valley office in Palo Alto, California.
-
February 09, 2026
Weil Helps Advent, FedEx Buy Poland's InPost For €7.8B
A consortium that includes U.S. private equity firm Advent International LP and FedEx Corp. said Monday that it has agreed to buy InPost for €7.8 billion ($9.2 billion) to back the growth in Europe of the Polish parcel locker company.
-
February 06, 2026
Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit
Takeda Pharmaceutical Co. and TWi Pharmaceuticals must face most of a proposed antitrust class action accusing them of delaying the release of the generic version of Takeda's heartburn medication Dexilant, causing Walgreens, Kroger and other retailers to pay more for the brand-name drug, a California federal judge ruled Friday.
-
February 06, 2026
News-Rating Biz Escalates Fight Against 'Retaliatory' FTC Deal
News-rating organization NewsGuard took aim Friday at a Federal Trade Commission settlement barring merging ad-buying giants from doing business with it, challenging that deal and an FTC subpoena in a D.C. federal court lawsuit alleging that both are "part of a broader retaliatory campaign" against NewsGuard and other sites.
-
February 06, 2026
'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.
D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt but also dodged opportunities to rule it out unequivocally.
-
February 06, 2026
STB Pledges 'Rigorous Review' Of UP, Norfolk Southern Deal
The Surface Transportation Board has reassured lawmakers that it will "conduct a rigorous and comprehensive review" of Union Pacific's proposed $85 billion merger with Norfolk Southern, as the board weighs a flurry of comments from industry stakeholders on the deal's sweeping implications for the U.S. economy.
-
February 06, 2026
Kroger And Albertsons Win Dismissal In Antitrust Labor Case
A Colorado federal judge on Friday dismissed a grocery store employee's proposed class action against Kroger and Albertsons alleging the pair violated antitrust law through a no-poach agreement to not hire competitor employees during a strike.
-
February 06, 2026
Judge Rejects Compass' Bid To Block Zillow Listing Rules
A New York federal court on Friday refused to bar Zillow from enforcing its updated listing policy while Compass brings its antitrust case alleging the rules are meant to block competition, after finding the brokerage has not shown its case is likely to succeed.
-
February 06, 2026
'Cardiac Pack' Wants NC Justices To Revive NIL Suit
A group of former student-athletes from the early 1980s is urging North Carolina's highest court to revive their name, image and likeness lawsuit against the NCAA, arguing the organization's use of gameplay footage to advertise March Madness is a continuing harm.
-
February 06, 2026
Ohio AG Sues Cannabis Cos. Over Cartel Pricing Scheme
The Ohio attorney general is suing nine multistate cannabis companies in state court, alleging that they have formed cartels to control cannabis prices and push smaller, independent operators out of the marketplace.
-
February 06, 2026
Ex-Yale New Haven Hospital Exec Drops Covenant Payment Suit
A Connecticut federal judge has accepted a deal to dismiss a lawsuit claiming Yale New Haven Hospital withheld $994,000 in contractually required payments to its former chief operating officer, but said the parties can reopen the dispute if they need the court's intervention.
-
February 06, 2026
Antitrust Classes Certified Over Altria's Juul Investment
A California federal court has certified several classes of Juul buyers in litigation over tobacco giant Altria's past investment in the e-cigarette company, despite concerns about the damages phase of the case becoming a "Frankenstein's monster."
-
February 06, 2026
NJ Watchdog Must Give Up Files In Hospital Row
A New Jersey federal judge has refused to disturb a magistrate judge's decision compelling a state watchdog to turn over documents from its inquiry into CarePoint Health Systems Inc., rejecting the agency's bid to shield its files with grand-jury-like secrecy and reaffirming that federal privilege law governs discovery disputes in federal court.
-
February 06, 2026
2nd Circ. Affirms Nix Of NY Anesthesiologists' Antitrust Suit
A New York anesthesiology practice didn't sustain an antitrust injury when a UnitedHealthcare unit used its market power to cut reimbursement rates, a Second Circuit panel affirmed Friday, finding that the change in rates was a natural consequence of the health insurance system and doesn't equate to anticompetitive harm.
-
February 06, 2026
FTC Scrutinizing Merger Creating $22B Chip Giant
Skyworks and Qorvo disclosed that the Federal Trade Commission had kicked off an in-depth probe that pumps the brakes on the two leading U.S.-based semiconductor-makers' plans to merge into a $22 billion industry giant.
Expert Analysis
-
Opinion
The Fallout Of Drake's Defamation Suit Against UMG
Hip-hop duo Clipse's recent comeback was caught in the undertow of the ongoing Drake v. Universal Music Group defamation litigation, which points to the troubling possibility that if labels can be held liable for promoting allegedly defamatory lyrics, they may preemptively sanitize content to avoid lawsuits, says Henry Williams IV at Gordon Rees.
-
Filing Clarifies FTC, DOJ's Passive Investment Stance
The antitrust agencies' statement of interest filed in Texas v. Blackrock clarifies that certain forms of corporate governance engagement are permissible under the "solely for investment" exemption, a move that offers guidance for passive investors but also signals new scrutiny of coordinated engagement, say attorneys at Stinson.
-
Lessons From 7th Circ.'s Deleted Chat Sanctions Ruling
The Seventh Circuit’s recent decision in Pable v. Chicago Transit Authority, affirming the dismissal of an ex-employee’s retaliation claims, highlights the importance of properly handling the preservation of ephemeral messages and clarifies key sanctions issues, says Philip Favro at Favro Law.
-
Opinion
Sometimes Int'l Competition Should Trump Antitrust Concerns
The U.S. Justice Department's approval of HPE's $14 billion acquisition of Juniper Networks shows that a merger that significantly enhances innovation and competitiveness may serve consumer and national interests despite marginally increasing industry concentration, says John Reeves at Reeves Law.
-
Series
Quilting Makes Me A Better Lawyer
Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham.
-
A Look At Robinson-Patman Enforcement In The MLM Industry
The Federal Trade Commission's recent focus on price discrimination in high-profile speeches and litigation suggests a renewed interest around Robinson-Patman Act enforcement, particularly in multilevel marketing, making it an apt time for direct sellers to audit their pricing, say Katrina Eash at Winston & Strawn and Juliet Belling Warren and Branko Jovanovic at Edgeworth Economics.
-
What 2 Profs Noticed As Transactional Law Students Used AI
After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.
-
State AGs Are Turning Up The Antitrust Heat On ESG Actions
Recent antitrust developments from red state attorneys general continue a trend of environmental, social and governance scrutiny, and businesses exposed to these areas should conduct close examinations of strategy and potential material risk, say attorneys at Morgan Lewis.
-
Rebuttal
BigLaw Settlements Should Not Spur Ethics Deregulation
A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.
-
Opinion
8th Circ. Should Reaffirm False Commercial Speech's Nature
The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.
-
How Big Pharma Has Responded To FTC Delisting Demands
Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.
-
Unpacking Ore. Law's Limits On PE Healthcare Investment
A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.
-
5 Ways Lawyers Can Earn Back The Public's Trust
Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.
-
Class Actions At The Circuit Courts: August Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.
-
Series
Hiking Makes Me A Better Lawyer
On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.